AHK-Cu side effects and risks

A copper peptide used in scalp serums, with laboratory findings and weak patent-only human data.

Also called: Ala-His-Lys copper complex, L-alanyl-L-histidyl-L-lysine copper(II), Copper tripeptide-3.

Healing and repair peptides · Copper-bound tripeptide.

Local redness or irritation: Patent mixture patch test: 1/33 reacted versus 0/33 with water; not an AHK Cu specific rate., mild. Stop if redness or stinging persists. (source)
Itchy rash or allergy to the formula: No AHK Cu specific rate; cosmetic ingredients can cause allergy., moderate. Stop and seek assessment for a spreading or persistent rash. (source)
Hair tint change: One forum commenter reported a tint change without thicker or new hair., mild. Record the change and stop if unwanted. (source)

Trouble breathing, throat swelling, fainting or chest pain after application: Stop and call emergency services now.
Spreading scalp redness, pus, fever or severe pain after needling: Stop and seek urgent assessment for possible infection.
Severe eye pain or a new vision change after eye-area exposure: Stop and get urgent eye care.

pregnant: No pregnancy safety data located. Precautionary block, not a proven fetal harm.
breastfeeding: Milk transfer and infant safety are unknown. Precautionary block.
tryingToConceive: Reproductive safety has not been studied. Precautionary block.
under18: No pediatric safety evidence located. Precautionary adult-only screen.
activeCancer: Cell-growth effects raise a theoretical concern; cancer safety is unknown. Precautionary block.
other: Copper handling is impaired. Topical AHK-Cu absorption is unknown; review with the treating specialist.
other: Avoid the ingredient that caused the reaction, including fragrances or preservatives.
other: Cosmetic serum safety on an open skin barrier is unproven. Needling adds infection and irritation risks.
testedAthlete: S0 may apply to unapproved pharmacological use. Obtain an anti-doping ruling before use.

Other copper peptides or copper products: Combined exposure is untested; mixing also changes the formula.
Copper-removing medicines: Theoretical conflict with copper-overload care. No topical AHK-Cu interaction study exists.
Minoxidil and other scalp medicines: Co-use is reported; no controlled AHK-Cu combination trial establishes benefit or compatibility.
Blood thinners when combined with microneedling: Needling adds bleeding risk; FDA flags blood thinners. This is a procedure risk, not a proven topical AHK-Cu interaction.

No independent survey testing online AHK-Cu products was located. Mislabeling and contamination rates are unknown.
AHK-Cu and GHK-Cu differ; a generic copper-peptide claim does not establish identity.
Water, raw materials and weak preservation can contaminate a serum. A purity percentage does not establish microbial safety.

Related to AHK-Cu

BPC-157: An experimental repair peptide with mostly animal evidence and a few small human reports.
TB-500: A short piece of thymosin beta-4 with no proven repair benefit in humans.
GHK-Cu: A copper-binding skin peptide with small topical studies and untested systemic injections.
Thymosin beta-4: A peptide studied for eye conditions and skin wounds; tendon-repair injections lack controlled human evidence.
ARA-290: Experimental peptide studied for small-fiber nerve damage, with uncertain pain relief and safety.
Ac-SDKP: An experimental repair peptide with old human studies, but no proven healing dose.

Sources checked: 2026-10-18.

Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.